Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-24-037875
Filing Date
2024-12-18
Accepted
2024-12-18 17:01:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 mnpr20241217_424b3.htm 424B3 117818
2 image4.jpg GRAPHIC 7268
  Complete submission text file 0001437749-24-037875.txt   128933
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283537 | Film No.: 241560107
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)